- Report
- February 2024
- 185 Pages
Global
From €4205EUR$4,500USD£3,513GBP
- Report
- October 2023
- 128 Pages
North America
From €3738EUR$4,000USD£3,122GBP
- Report
- October 2023
- 178 Pages
Global
From €4205EUR$4,500USD£3,513GBP
- Report
- August 2025
- 82 Pages
India
From €3270EUR$3,500USD£2,732GBP
- Report
- April 2025
- 85 Pages
India
From €3270EUR$3,500USD£2,732GBP
- Report
- January 2025
- 85 Pages
Saudi Arabia
From €3270EUR$3,500USD£2,732GBP
- Report
- September 2024
- 82 Pages
Japan
From €3270EUR$3,500USD£2,732GBP
- Report
- July 2024
- 100 Pages
Global
From €3504EUR$3,750USD£2,927GBP
- Report
- July 2024
- 100 Pages
Global
From €3504EUR$3,750USD£2,927GBP
- Report
- November 2023
- 30 Pages
Global
From €3037EUR$3,250USD£2,537GBP
- Report
- July 2024
- 120 Pages
Global
From €4438EUR$4,750USD£3,708GBP
- Report
- July 2024
- 150 Pages
Global
From €3504EUR$3,750USD£2,927GBP
- Report
- June 2025
- 250 Pages
India
From €2606EUR$2,789USD£2,177GBP
- Report
- June 2025
- 300 Pages
Latin America
From €3615EUR$3,869USD£3,020GBP
- Report
- June 2025
- 250 Pages
Japan
From €2606EUR$2,789USD£2,177GBP
- Report
- October 2024
- 200 Pages
Global
From €4624EUR$4,949USD£3,863GBP
- Report
- October 2024
- 200 Pages
Global
From €4624EUR$4,949USD£3,863GBP
- Report
- August 2024
- 200 Pages
Global
From €3615EUR$3,869USD£3,020GBP
- Report
- December 2023
- 160 Pages
United States
From €2606EUR$2,789USD£2,177GBP
- Report
- April 2023
- 147 Pages
Global
From €4624EUR$4,949USD£3,863GBP

The Vaccine Development market is a subset of the Vaccines industry, which focuses on the research, development, and production of vaccines. Vaccines are biological preparations that provide active acquired immunity to a particular disease. Vaccine development involves the identification of antigens, the development of a vaccine formulation, and the production of the vaccine. Vaccine development is a complex process that requires significant resources and expertise.
The Vaccine Development market is highly competitive, with many companies competing to develop and produce vaccines. Companies in the market include Merck & Co., GlaxoSmithKline, Sanofi, Pfizer, Johnson & Johnson, and Novavax. Show Less Read more